Triple negative breast cancer (TNBC) is one of the most aggressive subtypes of breast cancer with poor response to conventional therapy due to a lack of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene PGR and triple-negative breast carcinoma.